FIELD: immunology.
SUBSTANCE: invention relates to preparation of composition containing agent targeted to interleukin-15 (IL-5) receptor as the first active ingredient and agent targeted to interleukin-2 (IL-2) receptor as the second active ingredient; as well as methods for immune response suppression. Said compositions are useful in combined therapy: two or more agent which advance T-cell death or at least one agent which inhibits T-cell proliferation.
EFFECT: immunotherapy of increased effectiveness.
34 cl, 13 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHOD FOR IMMUNOSUPPRESSION | 2001 |
|
RU2270691C2 |
| HOMOGENOUS PREPARATIONS OF IL-28 AND IL-29 | 2004 |
|
RU2518324C2 |
| METHOD AND COMPOSITIONS FOR CELL IMMUNOTHERAPY | 2013 |
|
RU2700765C2 |
| METHOD OF TREATING AND PREVENTING FIBROSIS BY IL-21/IL-21R ANTAGONISTS | 2006 |
|
RU2419450C2 |
| ELEMENT BOUND WITH INTERLEUKIN-4 RECEPTOR α (IL-4Rα)-173 | 2008 |
|
RU2490278C2 |
| ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33) | 2015 |
|
RU2693084C2 |
| SELECTIVE AGONISTS AND ANTAGONISTS OF IL-2 | 1999 |
|
RU2235729C2 |
| ANTIBODIES BINDING IL-4 AND/OR IL-13, AND THEIR USE | 2015 |
|
RU2721236C2 |
| LIGAND GITR AND MOLECULES AND ANTIBODIES BOUND WITH LIGAND GITR, AND VERSIONS OF THEIR APPLICATION | 2004 |
|
RU2369636C2 |
| ANTIBODIES BINDING IL-4 AND/OR IL-13, AND USE THEREOF | 2015 |
|
RU2705551C2 |
